FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Care and Connection That Matter

Access to care, trusted guidance, and meaningful programs that support individuals and families—every step of the way.

MDA Engage Community Education Seminar: Kansas

Saturday, November 16, 2019MDA Engage Logo
Registration: 9:00am - 10:00am
Event: 10:00am - 4:00pm (lunch included)
Social Hour: 4:00pm - 5:00pm

Event Chair: Dr. Jeffrey Statland, Director, MDA Care Center, University of Kansas Medical Center

Event Location:
DoubleTree by Hilton Hotel Kansas City - Overland Park
10100 College Blvd
Overland Park, KS 66210

There is no cost to attend the event, however, registration is required.

Registration has Closed

  • Keynote Presentation- Advances in NMD Medicine
    • Jeffrey Statland, MD – University of Kansas
  • Research and Clinical Trial Review
    • Jeffrey Statland, MD – University of Kansas Medical Center
    • Michaela Walker – University of Kansas
  • Becoming your Own Advocate/ Peds to Adult Transition
    • Kathy Davis, PhD – University of Kansas
  • Genetic Testing
    • Raghav Govindarajan, MD – University of Missouri
  • Best Practices in Clinical Care
    • Constantine Farmakidis, MD – University of Kansas

 

Thank you to our supporters:

  • Sanofi Genzyme
  • AveXis
  • Genentech

For questions reach out to: mdaengage@mdausa.org | 1-833-ASK-MDA1 (1-833-275-6321)